Human macrophage response to L. (Viannia) panamensis: microarray evidence for an early inflammatory response
- PMID: 23145196
- PMCID: PMC3493378
- DOI: 10.1371/journal.pntd.0001866
Human macrophage response to L. (Viannia) panamensis: microarray evidence for an early inflammatory response
Abstract
Background: Previous findings indicate that susceptibility to Leishmania (Viannia) panamensis infection of monocyte-derived macrophages from patients and asymptomatically infected individuals were associated with the adaptive immune response and clinical outcome.
Methodology/principal findings: To understand the basis for this difference we examined differential gene expression of human monocyte-derived macrophages following exposure to L. (V.) panamensis. Gene activation profiles were determined using macrophages from healthy volunteers cultured with or without stationary phase promastigotes of L. (V.) panamensis. Significant changes in expression (>1.5-fold change; p<0.05; up- or down-regulated) were identified at 0.5, 4 and 24 hours. mRNA abundance profiles varied over time, with the highest level of activation occurring at earlier time points (0.5 and 4 hrs). In contrast to observations for other Leishmania species, most significantly changed mRNAs were up- rather than down-regulated, especially at early time points. Up-regulated transcripts over the first 24 hours belonged to pathways involving eicosanoid metabolism, oxidative stress, activation of PKC through G protein coupled receptors, or mechanism of gene regulation by peroxisome proliferators via PPARα. Additionally, a marked activation of Toll-receptor mediated pathways was observed. Comparison with published microarray data from macrophages infected with L. (Leishmania) chagasi indicate differences in the regulation of genes involved in signaling, motility and the immune response.
Conclusions: Results show that the early (0.5 to 24 hours) human monocyte-derived macrophage response to L. (Viannia) panamensis is not quiescent, in contrast to published reports examining later response times (48-96 hours). Early macrophage responses are important for the developing cellular response at the site of infection. The kinetics and the mRNA abundance profiles induced by L. (Viannia) panamensis illustrate the dynamics of these interactions and the distinct biologic responses to different Leishmania species from the outset of infection within their primary host cell.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures

Similar articles
-
Profiling gene expression of antimony response genes in Leishmania (Viannia) panamensis and infected macrophages and its relationship with drug susceptibility.Acta Trop. 2017 Dec;176:355-363. doi: 10.1016/j.actatropica.2017.08.017. Epub 2017 Aug 24. Acta Trop. 2017. PMID: 28843396 Free PMC article.
-
Toll-like receptors participate in macrophage activation and intracellular control of Leishmania (Viannia) panamensis.Infect Immun. 2011 Jul;79(7):2871-9. doi: 10.1128/IAI.01388-10. Epub 2011 Apr 25. Infect Immun. 2011. PMID: 21518783 Free PMC article.
-
Interplay of human macrophage response and natural resistance of L. ( V .) panamensis to pentavalent antimony.bioRxiv [Preprint]. 2024 Nov 2:2024.10.29.620724. doi: 10.1101/2024.10.29.620724. bioRxiv. 2024. PMID: 39553936 Free PMC article. Preprint.
-
Early Leukocyte Responses in Ex-Vivo Models of Healing and Non-Healing Human Leishmania (Viannia) panamensis Infections.Front Cell Infect Microbiol. 2021 Sep 7;11:687607. doi: 10.3389/fcimb.2021.687607. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34557423 Free PMC article.
-
Leishmania Viannia guyanensis, LRV1 virus and extracellular vesicles: a dangerous trio influencing the faith of immune response during muco-cutaneous leishmaniasis.Curr Opin Immunol. 2020 Oct;66:108-113. doi: 10.1016/j.coi.2020.08.004. Epub 2020 Aug 30. Curr Opin Immunol. 2020. PMID: 32877837 Review.
Cited by
-
Transcriptomic Analysis in Human Macrophages Infected with Therapeutic Failure Clinical Isolates of Leishmania infantum.ACS Infect Dis. 2022 Apr 8;8(4):800-810. doi: 10.1021/acsinfecdis.1c00513. Epub 2022 Mar 30. ACS Infect Dis. 2022. PMID: 35352952 Free PMC article.
-
Comparative analysis of resistant and susceptible macrophage gene expression response to Leishmania major parasite.BMC Genomics. 2013 Oct 22;14:723. doi: 10.1186/1471-2164-14-723. BMC Genomics. 2013. PMID: 24148319 Free PMC article.
-
Local Delivery of the Toll-Like Receptor 9 Ligand CpG Downregulates Host Immune and Inflammatory Responses, Ameliorating Established Leishmania (Viannia) panamensis Chronic Infection.Infect Immun. 2017 Feb 23;85(3):e00981-16. doi: 10.1128/IAI.00981-16. Print 2017 Mar. Infect Immun. 2017. PMID: 28052994 Free PMC article.
-
Transcriptomics analysis highlights potential ways in human pathogenesis in Leishmania braziliensis infected with the viral endosymbiont LRV1.PLoS Negl Trop Dis. 2024 May 14;18(5):e0012126. doi: 10.1371/journal.pntd.0012126. eCollection 2024 May. PLoS Negl Trop Dis. 2024. PMID: 38743668 Free PMC article.
-
Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures.mBio. 2016 May 10;7(3):e00027-16. doi: 10.1128/mBio.00027-16. mBio. 2016. PMID: 27165796 Free PMC article.
References
-
- Bosque F, Saravia NG, Valderrama L, Milon G (2000) Distinct innate and acquired immune responses to Leishmania in putative susceptible and resistant human populations endemically exposed to L. (Viannia) panamensis infection. Scand J Immunol 51: 533–541. - PubMed
-
- Farrell J (2002) Leishmania; Balck SJ, Seed JR, editors. Boston, Mass.: Kluwer Academic Publishers. 193 p.
-
- Peters W, Killick-Kendrick R (1987) The leishmaniases in biology and medicine. London; Orlando: Academic Press. 2 v. (xxv, 941, xxviii p.) p.
Publication types
MeSH terms
Substances
Grants and funding
- R01 AI045540/AI/NIAID NIH HHS/United States
- P50 AI030639/AI/NIAID NIH HHS/United States
- AI076233/AI/NIAID NIH HHS/United States
- U19 AI065866/AI/NIAID NIH HHS/United States
- D43 TW006589/TW/FIC NIH HHS/United States
- AI045540/AI/NIAID NIH HHS/United States
- R01 AI076233/AI/NIAID NIH HHS/United States
- R01 AI093775/AI/NIAID NIH HHS/United States
- TMRC P50 AI-30639/AI/NIAID NIH HHS/United States
- 1D43TW006589/TW/FIC NIH HHS/United States
- 1U19 AI065866/AI/NIAID NIH HHS/United States
- T32 GM007337/GM/NIGMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Molecular Biology Databases